Can systems toxicology identify common biomarkers of non-genotoxic carcinogenesis?

Toxicology

Volumn 254, Issue 3, 2008, Pages 164-169

  Plant, Nick ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

Biomarker; Expression signature; Genotoxic carcinogenesis; Non genotoxic carcinogenesis; Systems toxicology

Indexed keywords

BIOLOGICAL MARKER; CARCINOGEN; PROTEOME; TRANSCRIPTOME;

CARCINOGENESIS; DNA DAMAGE; DNA MICROARRAY; GENOME; GENOMICS; GENOTOXICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SPECIES DIFFERENCE; TRANSCRIPTOMICS;

ANIMALS; CARCINOGENICITY TESTS; CARCINOGENS; HUMANS; SPECIES SPECIFICITY; SYSTEMS BIOLOGY; TOXICOLOGY; TUMOR MARKERS, BIOLOGICAL;

EID: 56349118797     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2008.07.001     Document Type: Review

References (65)

1. Ames B., Lee F., and Durston W. An improved bacterial test system for the detection and classification of mutagens and carcinogens. Proceeding of the National Academy of Sciences United States of America 70 (1973) 782-786
2. Ames B.N., and Gold L.S. Chemical carcinogenesis: too many rodent carcinogens. Proceedings of the National Academy of Sciences United States of America 87 (1990) 7772-7776
3. Aouabdi S., Gibson G.G., and Plant N. Transcriptional regulation of PXR: identification of a PPRE within the proximal promoter responsible for fibrate-mediated transcriptional activation of PXR. Drug Metabolism and Disposition 34 (2006) 138-144
4. Ashby J., and Tennant R.W. Definitive relationships among chemical structure, carcinogenicity and mutagenicity for 301 chemicals tested by the U.S. NTP. Mutation Research 257 (1991) 229-306
5. Bolt H.M., Foth H., Hengstler J.G., and Degen G.H. Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective. Toxicology Letters 151 (2004) 29-41
6. Brendler-Schwaab S., Hartmann A., Pfuhler S., and Speit G. The in vivo comet assay: use and status in genotoxicity testing. Mutagenesis 20 (2005) 245-254
7. Cherkaoui-Malki M., Meyer K., Cao W.Q., Latruffe N., Yeldandi A.V., Rao M.S., Bradfield C.A., and Reddy J.K. Identification of novel peroxisome proliferator-activated receptor alpha (PPARalpha) target genes in mouse liver using cDNA microarray analysis. Gene Expression 9 (2001) 291-304
8. Chipman J.K., Mally A., and Edwards G.O. Disruption of gap junctions in toxicity and carcinogenicity. The Journal of Toxicological Sciences 71 (2003) 146-153
9. Christmann M., and Kaina B. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents. Journal of Biological Chemistry 275 (2000) 36256-36262
10. Chu R., Zhang W., Lim H., Yeldandi A.V., Herring C., Brumfield L., Reddy J.K., and Davison M. Profiling of acyl-CoA oxidase-deficient and peroxisome proliferator Wy14,643-treated mouse liver protein by surface-enhanced laser desorption/ionization ProteinChip biology system. Gene Expression 10 (2002) 165-177
11. Collins B.C., Clarke A., Kitteringham N.R., Gallagher W.M., and Pennington S.R. Use of proteomics for the discovery of early markers of drug toxicity. Expert Opinion in Drug Metabolism and Toxicology 3 (2007) 689-704
12. Crunkhorn S.E., Plant K.E., Gibson G.G., Kramer K., Lyon J., Lord P.G., and Plant N.J. Gene expression changes in rat liver following exposure to liver growth agents: role of Kupffer cells in xenobiotic-mediated liver growth. Biochemical Pharmacology 67 (2004) 107-118
13. Dahl E., Kristiansen G., Gottlob K., Klaman I., Ebner E., Hinzmann B., Hermann K., Pilarsky C., Durst M., Klinkhammer-Schalke M., Blaszyk H., Knuechel R., Hartmann A., Rosenthal A., and Wild P.J. Molecular profiling of laser-microdissected matched tumor and normal breast tissue identifies karyopherin alpha2 as a potential novel prognostic marker in breast cancer. Clinical Cancer Research 12 (2006) 3950-3960
14. Delaney J., Hodson M.P., Thakkar H., Connor S.C., Sweatman B.C., Kenny S.P., McGill P.J., Holder J.C., Hutton K.A., Haselden J.N., and Waterfield C.J. Tryptophan-NAD+ pathway metabolites as putative biomarkers and predictors of peroxisome proliferation. Archives of Toxicology 79 (2005) 208-223
15. Della Porta G., and Dragani T.A. Long-term assays for carcinogenicity. Teratogenesis, Carcinogenesis and Mutagenesis 10 (1990) 137-145
16. Ekins S. Systems-ADME/Tox: resources and network approaches. Journal of Pharmacological and Toxicological Methods 53 (2006) 38-66
17. Ferguson L.R., and Denny W.A. Genotoxicity of non-covalent interactions: DNA intercalators. Mutation Research 623 (2007) 14-23
18. Fielden M.R., Brennan R., and Gollub J. A gene expression biomarker provides early prediction and mechanistic assessment of hepatic tumor induction by nongenotoxic chemicals. The Journal of Toxicological Sciences 99 (2007) 90-100
19. Fielden M.R., Nie A., McMillian M., Elangbam C.S., Trela B.A., Yang Y., Dunn II R.T., Dragan Y., Fransson-Stehen R., Bogdanffy M., Adams S.P., Foster W.R., Chen S.J., Rossi P., Kasper P., Jacobson-Kram D., Tatsuoka K.S., Wier P.J., Gollub J., Halbert D.N., Roter A., Young J.K., Sina J.F., Marlowe J., Martus H.J., Aubrecht J., Olaharski A.J., Roome N., Nioi P., Pardo I., Snyder R., Perry R., Lord P., Mattes W., and Car B.D. Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the rat. The Journal of Toxicological Sciences 103 (2008) 28-34
20. Freedman N.D., and Yamamoto K.R. Importin 7 and Importin α/Importin β are nuclear import receptors for the glucocorticoid receptor. Molecular and Cellular Biology (2004) (Epub)
21. Frijters R., Verhoeven S., Alkema W., Van Schaik R.H., and Polman J. Literature-based compound profiling: application to toxicogenomics. Pharmacogenomics 8 (2007) 1521-1534
22. Fukushima T., Kikkawa R., Hamada Y., and Horii I. Genomic cluster and network analysis for predictive screening for hepatotoxicity. The Journal of Toxicological Sciences 31 (2006) 419-432
23. Gaylor D.W. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?. Regulatory Toxicology and Pharmacology 41 (2005) 128-133
24. Gibson G.G., Phillips A., Aouabdi S., Plant K., and Plant N. Transcriptional regulation of the human pregnane-X receptor. Drug Metabolism Reviews 38 (2006) 31-49
25. Hartig F., Stegmeier K., and Hebold G. Study of liver enzymes: peroxisome proliferation and tumour rates in rats at the end of carcinogenicity studies with bezafibrate and clofibrate. Annals of the New York Academy of Science 386 (1982) 464-467
26. Jackson M., Stack H., and Waters M. The genetic toxicology pf putative nongenotoxic carcinogens. Mutation Research 296 (1993) 241-277
27. Kell D.B. Systems biology, metabolic modelling and metabolomics in drug discovery and development. Drug Discovery Today 11 (2006) 1085-1092
28. Kim I.S., Kim D.H., Han S.M., Chin M.U., Nam H.J., Cho H.P., Choi S.Y., Song B.J., Kim E.R., Bae Y.S., and Moon Y.H. Truncated form of importin alpha identified in breast cancer cell inhibits nuclear import of p53. Journal of Biological Chemistry 275 (2000) 23139-23145
29. Kirkland D., Aardema M., Henderson L., and Muller L. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens. I. Sensitivity, specificity and relative predictivity. Mutation Research 584 (2005) 1-256
30. Klaunig J., Xu Y., Bachowski S., Ketcham C., Isenberg J., Kolaja K., Baker T., Walborg E., and Stevenson D. Oxidative stress in nongenotoxic carcinogenesis. The Journal of Toxicological Letters 82/83 (1995) 683-691
31. Kohler M., Fiebeler A., Hartwig M., Thiel S., Prehn S., Kettritz R., Luft F.C., and Hartmann E. Differential expression of classical nuclear transport factors during cellular proliferation and differentiation. Cellular Physiology and Biochemistry 12 (2002) 335-344
32. Mann M., Ong S.E., Gronborg M., Steen H., Jensen O.N., and Pandey A. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends in Biotechnology 20 (2002) 261-268
33. Melen K., Fagerlund R., Franke J., Kohler M., Kinnunen L., and Julkunen I. Importin alpha nuclear localization signal binding sites for STAT1, STAT2, and influenza A virus nucleoprotein. Journal of Biological Chemistry 278 (2003) 28193-28200
34. Morrison V., and Ashby J. A preliminary evaluation of the performance of the Muta Mouse (lacZ) and Big Blue (lacI) transgenic mouse mutation assays. Mutagenesis 9 (1994) 367-375
35. Nie A.Y., McMillian M., Parker J.B., Leone A., Bryant S., Yieh L., Bittner A., Nelson J., Carmen A., Wan J., and Lord P.G. Predictive toxicogenomics approaches reveal underlying molecular mechanisms of nongenotoxic carcinogenicity. Molecular Carcinogenesis 45 (2006) 914-933
36. O'Brien T.J., Ceryak S., and Patierno S.R. Complexities of chromium carcinogenesis: role of cellular response, repair and recovery mechanisms. Mutation Research 533 (2003) 3-36
37. Patlewicz G., Rodford R., and Walker J.D. Quantitative structure-activity relationships for predicting mutagenicity and carcinogenicity. Environmental and Toxicological Chemistry 22 (2003) 1885-1893
38. Peters J.M., Cheung C., and Gonzalez F.J. Peroxisome proliferator-activated receptor-alpha and liver cancer: where do we stand?. Journal of Molecular Medicine 83 (2005) 774-785
39. Phillips A., Bullock T., and Plant N. Sodium valproate induces apoptosis in the rat hepatoma cell line, FaO. Toxicology 192 (2003) 219-227
40. Plant K.E., Everett D.M., Gordon Gibson G., Lyon J., and Plant N.J. Transcriptomic and phylogenetic analysis of Kpna genes: a family of nuclear import factors modulated in xenobiotic-mediated liver growth. Pharmacogenetics and Genomics 16 (2006) 647-658
41. Plant N. Interaction networks: coordinating responses to xenobiotic exposure. Toxicology 202 (2004) 21-32
42. Plant N. Strategies for using in vitro screens in drug metabolism. Drug Discovery Today 9 (2004) 328-336
43. Plant N.J., Horley N.J., Dickins M., Hasmall S.C., Elcombe C.R., and Bell D.R. The coordinate regulation of DNA synthesis and suppression of apoptosis is differentially regulated by the liver growth agents, phenobarbital and methylclofenapate. Carcinogenesis 19 (1998) 1521-1527
44. Powell D.W., Pierce W.M., and McLeish K.R. Defining mitogen-activated protein kinase pathways with mass spectrometry-based approaches. Mass Spectrometry Reviews 24 (2005) 847-864
45. Pritchard J.B., French J.E., Davis B.J., and Haseman J.K. The role of transgenic mouse models in carcinogen identification. Environmental Health Perspectives 111 (2003) 444-454
46. Pushparajah D.S., Umachandran M., Nazir T., Plant K.E., Plant N., Lewis D.F., and Ioannides C. Up-regulation of CYP1A/B in rat lung and liver, and human liver precision-cut slices by a series of polycyclic aromatic hydrocarbons; association with the Ah locus and importance of molecular size. Toxicology In Vitro 22 (2008) 128-145
47. Pushparajah D.S., Umachandran M., Plant K.E., Plant N., and Ioannides C. Differential response of human and rat epoxide hydrolase to polycyclic aromatic hydrocarbon exposure: studies using precision-cut tissue slices. Mutation Research 640 (2008) 153-161
48. Seidel S.D., Stott W.T., Kan H.L., Sparrow B.R., and Gollapudi B.B. Gene expression dose-response of liver with a genotoxic and nongenotoxic carcinogen. International Journal of Toxicology 25 (2006) 57-64
49. Snyder R.D., and Green J.W. A review of the genotoxicity of marketed pharmaceuticals. Mutation Research 488 (2001) 151-169
50. Steiner S., and Anderson N.L. Expression profiling in toxicology-potentials and limitations. Toxicology Letters 112-113 (2000) 467-471
51. Thomas R.S., O'Connell T.M., Pluta L., Wolfinger R.D., Yang L., and Page T.J. A comparison of transcriptomic and metabonomic technologies for identifying biomarkers predictive of two-year rodent cancer bioassays. The Journal of Toxicological Sciences 96 (2007) 40-46
52. Tinwell H., and Ashby J. Micronucleus morphology as a means to distinguish aneugens and clastogens in the mouse bone-marrow micronucleus assay. Mutagenesis 6 (1991) 193-198
53. Tryndyak V.P., Kovalchuk O., Muskhelishvili L., Montgomery B., Rodriguez-Juarez R., Melnyk S., Ross S.A., Beland F.A., and Pogribny I.P. Epigenetic reprogramming of liver cells in tamoxifen-induced rat hepatocarcinogenesis. Molecular Carcinogenesis 46 (2007) 187-197
54. Tryndyak V.P., Muskhelishvili L., Kovalchuk O., Rodriguez-Juarez R., Montgomery B., Churchwell M.I., Ross S.A., Beland F.A., and Pogribny I.P. Effect of long-term tamoxifen exposure on genotoxic and epigenetic changes in rat liver: implications for tamoxifen-induced hepatocarcinogenesis. Carcinogenesis 27 (2006) 1713-1720
55. Turteltaub K.W., Dingley K.H., Curtis K.D., Malfatti M.A., Turesky R.J., Garner R.C., Felton J.S., and Lang N.P. Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses. Cancer Letters 143 (1999) 149-155
56. Ulrich R.G., Rockett J.C., Gibson G.G., and Pettit S.D. Overview of an interlaboratory collaboration on evaluating the effects of model hepatotoxicants on hepatic gene expression. Environmental Health Perspectives 112 (2004) 423-427
57. van Delft J.H., van Agen E., van Breda S.G., Herwijnen M.H., Staal Y.C., and Kleinjans J.C. Discrimination of genotoxic from non-genotoxic carcinogens by gene expression profiling. Carcinogenesis 25 (2004) 1265-1276
58. van Delft J.H., van Agen E., van Breda S.G., Herwijnen M.H., Staal Y.C., and Kleinjans J.C. Comparison of supervised clustering methods to discriminate genotoxic from non-genotoxic carcinogens by gene expression profiling. Mutation Research 575 (2005) 17-33
59. Vrana K.E., Freeman W.M., and Aschner M. Use of microarray technologies in toxicology research. Neurotoxicology 24 (2003) 321-332
60. Waring J.F., Ciurlionis R., Jolly R.A., Heindel M., and Ulrich R.G. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicology Letters 120 (2001) 359-368
61. Yasmin R., Williams R.M., Xu M., and Noy N. Nuclear import of the retinoid X receptor, the vitamin D receptor, and their mutual heterodimer. Journal of Biological Chemistry 280 (2005) 40152-40160
62. Yu S., Cao W.Q., Kashireddy P., Meyer K., Jia Y., Hughes D.E., Tan Y., Feng J., Yeldandi A.V., Rao M.S., Costa R.H., Gonzalez F.J., and Reddy J.K. Human peroxisome proliferator-activated receptor alpha (PPARalpha) supports the induction of peroxisome proliferation in PPARalpha-deficient mouse liver. Journal of Biological Chemistry 276 (2001) 42485-42491
63. Zgoda V., Tikhonova O., Viglinskaya A., Serebriakova M., Lisitsa A., and Archakov A. Proteomic profiles of induced hepatotoxicity at the subcellular level. Proteomics 6 (2006) 4662-4670
64. Zhang H., LeCulyse E., Liu L., Hu M., Matoney L., Zhu W., and Yan B. Rat pregnane X receptor: molecular cloning, tissue distribution and xenobiotic regulation. Archives of Biochemistry and Biophysics 368 (1999) 14-22
65. Zito R. Low doses and thresholds in genotoxicity: from theories to experiments. Journal of Experimental and Clinical Cancer Research 20 (2001) 315-325